More than 45 encapsulated cell therapies and encapsulation technologies are being evaluated across different phases of development by stakeholders across the globe, claims Roots Analysis

Extensive research on cell encapsulation strategies has enabled the development of a variety of technologies capable of immobilizing / enclosing therapeutic entities within biocompatible matrices / carriers. Such products offer a myriad of advantages, and have demonstrated the capability to address existing challenges related to cell therapies and certain other types of interventions as well.

To order this 500+ page report, which features 170+ figures and 395+ tables, please visit this https://www.rootsanalysis.com/reports/249/request-sample.html

The USD 3.7 billion (by 2030) financial opportunity within the encapsulated cell therapies and encapsulation technologies market has been analyzed across the following segments:

• Type of licensing deal payment
• Upfront payment
• Milestone payment
• Therapeutic area
• Metabolic disorder
• Neurological disorder
• Ophthalmic disorder
• Oncological disorder
• Target disease indication
• Ataxia telangiectasia
• Breast cancer
• Diabetes
• Glaucoma
• Head and neck cancer
• Macular telangectasia
• Pancreatic cancer
• Parkinson’s disease
• Retinitis pigmentosa
• Type of encapsulation material used
• Alginate-based microcapsule
• Cellulose hydrogel
• Medical-grade plastic
• Red blood cell
• Key geographical region
• North America
• Europe
• Asia-Pacific and rest of the world

The Cell Encapsulation: Focus on Therapeutics and Technologies, 2019-2030 report features the following companies, which we identified to be key players in this domain: 

• ALTuCELL
• Azellon Cell Therapeutics
• Beta-Cell
• Betalin Therapeutics
• CellProtect Biotechnology
• Diatranz Otsuka
• Encellin
• EryDel
• Gloriana Therapeutics
• Living Cell Technologies
• MaxiVAX
• Neurotech Pharmaceuticals
• PharmaCyte Biotech
• Semma Therapeutics
• Sernova

Table of Contents

17. Preface
18. Executive Summary
19. Introduction
20. Current Market Landscape
21. Encapsulated Cell Therapies and Encapsulation Technologies for Metabolic Disorders: Company Profiles
22. Encapsulated Cell Therapies and Encapsulation Technologies for Non-Metabolic Disorders: Company Profiles
23. Patent Analysis
24. Clinical Trial Analysis
25. Recent Partnerships
26. Funding and Investment Analysis
27. Grant Analysis
28. Potential Strategic Partners
29. Market Forecast
30. Conclusion
31. Executive Insights
32. Appendix 1: Tabulated Data
33. Appendix 2: List of Companies and Organizations

To purchase a copy, please visit https://rootsanalysis.com/reports/view_document/cell-encapsulation-focus-on-therapeutics-and-technologies-2019-2030/249.html

Contact:

Gaurav Chaudhary
+1 (415) 800 3415
+44 (122) 391 1091
Gaurav.Chaudhary@rootsanalysis.com

Tags: Research, biotech, market size, pharma, report, Analysis, Alginate,  , Microcapsule, encapsulation, Cell Therapy, Roots Analysis, Encapsulated, Macrocapsule